Incidence, Predictors and Outcomes of Contrast Induced Nephropathy in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
References
- Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, Grazi M, Veglia F, Bartorelli AL. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004 Nov 2; 44(9): 1780–5. DOI: 10.1016/j.jacc.2004.07.043
- Khalfallah M, Abdalaal M, Adel M. Contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction: Is it affected by treatment strategy? Global Heart. 2019 Sep; 14(3): 295–302. DOI: 10.1016/j.gheart.2019.07.001
- Morcos SK, Thomsen HS, Webb JAW. Contrast media induced nephrotoxicity: A consensus report. Contrast media safety committee, European Society of Urogenital Radiology (ESUR). Eur J Radiol. 1999; 9: 1602–13. DOI: 10.1007/s003300050894
- McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol. 2006; 98: 5K–13K. DOI: 10.1016/j.amjcard.2006.01.019
- Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006; S11–15. DOI: 10.1038/sj.ki.5000368
- Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011; 58: e44–122.
- Senoo T, Motohiro M, Kamihata H, et al. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Car- diol. 2010; 105: 624–8. DOI: 10.1016/j.amjcard.2009.10.044
- Brar SS, Aharonian V, Mansukhani P, et al. Hemodynamic guided fluid administration for the prevention of contrast-induced acute kidney injury: The POSEIDON randomised controlled trial. Lancet. 2014; 383: 1814–23. DOI: 10.1016/S0140-6736(14)60689-9
- Khalfallah M, Abdelmageed R, Allaithy A. Very Early Versus Early Percutaneous Coronary Intervention in Patients with Decreased e-GFR after Successful Fibrinolytic Therapy. Glob Heart. 2020 Apr 16; 15(1): 34. DOI: 10.5334/gh.794
- Menown IB, Mackenzie G, Adgey AA. Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction. Eur Heart J. 2000 Feb; 21(4): 275–83. DOI: 10.1053/euhj.1999.1748
- National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis. 2002 Feb; 39(2 Suppl 1): S1–266.
- Briguori C, Visconti G, Rivera NV, Focaccio A, Golia B, Giannone R, Castaldo D, De Micco F, Ricciardelli B, Colombo A. Cystatin C and contrast-induced acute kidney injury. Circulation. 2010; 121: 2117–2122. DOI: 10.1161/CIRCULATIONAHA.109.919639
- Van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A, Menon V, Ohman EM, Sweitzer NK, Thiele H, Washam JB, Cohen MG. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017; 136: e232–e268. DOI: 10.1161/CIR.0000000000000525
- Rao SV, McCoy LA, Spertus JA, et al. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry. JACC Cardiovasc Interv. 2013; 6: 897–904. DOI: 10.1016/j.jcin.2013.04.016
- Kirma C, Izgi A, Dundar C, Tanalp AC, Oduncu V, Aung SM. Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions: experience at a single center. Circ J. 2008; 72: 716–721. DOI: 10.1253/circj.72.716
- Mehran R, Aymong ED, Nikolsky, E, et al. A simple risk score for prediction of contrast4-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 44(2004): 1393–1399. DOI: 10.1016/S0735-1097(04)01445-7
- Bouzas-Mosquera A, Vazquez-Rodriguez JM, Calvino-Santos R, et al. Contrast induced nephropathy and acute renal failure following emergent cardiac catheterization: Incidence, risk factors and prognosis. Rev Esp Cardiol. 2007; 60: 1026–34. DOI: 10.1157/13111234
- Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 39(2002): 930–936. DOI: 10.1053/ajkd.2002.32766
- Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation 2003; 107: 2920. DOI: 10.1161/01.CIR.0000072767.89944.6E
- Khalfallah M, Elsheikh A. Incidence, predictors, and outcomes of new-onset atrial fibrillation in patients with ST-elevation myocardial infarction. Ann Noninvasive Electrocardiol. 2020 Jul; 25(4):
e12746 . Epub 2020 Jan 23. DOI: 10.1111/anec.12746 - Pizzetti F, Turazza FM, Franzosi MG, Barlera S, Ledda A, Maggioni AP, Santoro L, Tognoni G, GISSI-3 Investigators. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart. 2001; 86: 527–32. DOI: 10.1136/heart.86.5.527
- Diogo LP, Saitovitch D, Biehl M, Bahlis LF, Guterres MC, O’Keeffe CF, Carvalhal GF, Caramori PR. Is there an association between non-steroidal anti-inflammatory drugs and contrast nephropathy? Arq Bras Cardiol. 2010 Dec; 95(6): 726–31. Epub 2010 Nov 12. DOI: 10.1590/S0066-782X2010005000145
- Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002; 105: 2259–64. DOI: 10.1161/01.CIR.0000016043.87291.33
- Newhouse JH, RoyChoudhury A. Quantitating contrast medium-induced nephropathy: Controlling the controls. Radiology. 2013; 267: 4–8. DOI: 10.1148/radiol.13122876
- Kooiman J, Seth M, Nallamothu BK, Heung M, Humes D, Gurm HS. Association between acute kidney injury and in-hospital mortality in patients undergoing percutaneous coronary interventions. Circ Cardiovasc Interv. 2015; 8:
e002212 . DOI: 10.1161/CIRCINTERVENTIONS.114.002212 - Marenzi G, Assanelli E, Campodonico J, Lauri G, Marana I, De Metrio M, Moltrasio M, Grazi M, Rubino M, Veglia F, Fabbiocchi F, Bartorelli AL. Contrast volume during primary percutaneous coronary intervention and subsequent contrast induced nephropathy and mortality. Ann Intern Med. 2009; 150: 170–177. DOI: 10.7326/0003-4819-150-3-200902030-00006
- Narula A, Mehran R, Weisz G, Dangas GD, Yu J, Genereux P, Nikolsky E, Brener SJ, Witzenbichler B, Guagliumi G, Clark AE, Fahy M, Xu K, Brodie BR, Stone GW. Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI sub study. Eur Heart J. 2014; 35: 1533–1540. DOI: 10.1093/eurheartj/ehu063
DOI: https://doi.org/10.5334/gh.1071 | Journal eISSN: 2211-8179
Language: English
Submitted on: May 31, 2021
Accepted on: Jul 23, 2021
Published on: Aug 31, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2021 Mohamed Khalfallah, Amany Allaithy, Dina A. Maria, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.